CID 201194

Piperazine, 1-(1,4-benzodioxan-6-ylcarbonyl)-4-(1,4-benzodioxan-6-ylmethyl)-, hydrochloride

Structural Information

Molecular Formula
C22H24N2O5
SMILES
C1CN(CCN1CC2=CC3=C(C=C2)OCCO3)C(=O)C4=CC5=C(C=C4)OCCO5
InChI
InChI=1S/C22H24N2O5/c25-22(17-2-4-19-21(14-17)29-12-10-27-19)24-7-5-23(6-8-24)15-16-1-3-18-20(13-16)28-11-9-26-18/h1-4,13-14H,5-12,15H2
InChIKey
KZJKSDJVQWSVFO-UHFFFAOYSA-N
Compound name
2,3-dihydro-1,4-benzodioxin-6-yl-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperazin-1-yl]methanone
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

396.16852 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 397.17580 194.7
[M+Na]+ 419.15774 197.5
[M-H]- 395.16124 203.3
[M+NH4]+ 414.20234 197.8
[M+K]+ 435.13168 197.8
[M+H-H2O]+ 379.16578 182.1
[M+HCOO]- 441.16672 200.1
[M+CH3COO]- 455.18237 201.3
[M+Na-2H]- 417.14319 197.4
[M]+ 396.16797 191.0
[M]- 396.16907 191.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.